Orchidams Equities

Orchid AMS Aims for Rs 300 Crore Turnover in Antimicrobial Resistance Sector Within Three Years Sep 22, 2024

Orchid AMS Targets 300 Crore Revenue from Antimicrobial Resistance Business Sep 22, 2024